Technology Review - Published By MIT
Advertisement
TR35

2009 Young Innovator

Erez Lieberman-Aiden, 29

Harvard University/MIT

Quantitative tools offer new insights into evolution

When Erez Lieberman-Aiden started his PhD in applied math in 2003, evolutionary theory couldn't handle the complex shapes of real-world populations. So he helped it adapt by combining it with specialized mathematical tools. His advances at the Harvard-MIT Division of Health Sciences and Technology have allowed evolutionary biologists to include more variables in their models.

His next challenge: "People talk about the evolution of culture and language, but I found myself wondering whether evolution is really relevant to culture," Lieberman-Aiden says. Working with Google, he and colleagues are building tools that can scan massive collections of digital texts and quantify how often a word--say, communism--appears in those from a particular era and place. This makes it easy to observe the movement of ideas, culture, and language across time and space.

Recently, Lieberman-Aiden has shifted his research toward genomics. Scientists can determine the sequence of bases in DNA, but they've had no way to know the genome's overall structure. L­ieberman-Aiden has co­developed a method that determines both sequence and structure--revealing, for instance, conformational changes that bring two genes close even though they're far apart along the length of a chromosome.--Erika Jonietz

 
 
TR35 Back to all TR35 2009 Winners   TR35 2009 Biomedicine Winners     
Jorge Conde
Offering consumers whole-genome sequencing--and software to interpret it
José Gómez-Márquez
Practical medical devices for use in poor countries
Michelle Khine
A children’s toy inspires a cheap, easy production method for high-tech diagnostic chips
Erez Lieberman-Aiden
Quantitative tools offer new insights into evolution
Andrew Lynn
Repairing joints by stimulating regrowth in bone and cartilage
Ellis Meng
Micropumps deliver drugs that prevent blindness
C. Shad Thaxton
Nanoparticles could treat cardiovascular disease by mimicking “good cholesterol”

Comments

Advertisement
MIT Massachusetts Institute of Technology © 2010 Technology Review. All Rights Reserved.